SNG001
SNG001 is a drug used to treat COVID-19, Coronavirus, Covid19, and other conditions. SNG001 is being actively studied in 2 studies and prior, has been studied in 1.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Synairgen Research Ltd. | AGA Clinical Trials (Site 1026), 900 West 49th Street | |
| National Institute of Allergy and Infectious Diseases (NIAID) | AIDS Research and Treatment Center of the Treasure Coast (Site 1095), 981 37th Place | |
| AOU Federico II - Malattie Inf |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Active, not recruiting
- SARS-CoV-2
- SNG001
- Placebo
- Belfast, United Kingdom
- +12 more
2021-03-19
Mar 19, 2021S
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVID-19
- SNG001
- Placebo
- Tucson, Arizona
- +111 more
2022-03-02
Mar 2, 2022N
Active, not recruiting
- Coronavirus
- Covid19
- bamlanivimab
- +14 more
- Anniston, Alabama
- +250 more
2022-03-17
Mar 17, 2022